5g5w

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
m (Protected "5g5w" [edit=sysop:move=sysop])
Current revision (13:39, 26 July 2023) (edit) (undo)
 
(3 intermediate revisions not shown.)
Line 1: Line 1:
-
'''Unreleased structure'''
 
-
The entry 5g5w is ON HOLD
+
==Structure guided design and discovery of Indazole ethers as highly potent, non-steroidal Glucocorticoid receptor modulators==
 +
<StructureSection load='5g5w' size='340' side='right'caption='[[5g5w]], [[Resolution|resolution]] 2.20&Aring;' scene=''>
 +
== Structural highlights ==
 +
<table><tr><td colspan='2'>[[5g5w]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5G5W OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5G5W FirstGlance]. <br>
 +
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.2&#8491;</td></tr>
 +
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=R8C:2,2,2-TRIFLUORO-N-[(1R,2S)-1-{[1-(4-FLUOROPHENYL)-1H-INDAZOL-5-YL]OXY}-1-PHENYLPROPAN-2-YL]ACETAMIDE'>R8C</scene></td></tr>
 +
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5g5w FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5g5w OCA], [https://pdbe.org/5g5w PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5g5w RCSB], [https://www.ebi.ac.uk/pdbsum/5g5w PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5g5w ProSAT]</span></td></tr>
 +
</table>
 +
== Disease ==
 +
[https://www.uniprot.org/uniprot/GCR_HUMAN GCR_HUMAN] Defects in NR3C1 are a cause of glucocorticoid resistance (GCRES) [MIM:[https://omim.org/entry/138040 138040]; also known as cortisol resistance. It is a hypertensive, hyperandrogenic disorder characterized by increased serum cortisol concentrations. Inheritance is autosomal dominant.<ref>PMID:12050230</ref> <ref>PMID:1704018</ref> <ref>PMID:7683692</ref> <ref>PMID:11589680</ref> <ref>PMID:11701741</ref>
 +
== Function ==
 +
[https://www.uniprot.org/uniprot/GCR_HUMAN GCR_HUMAN] Receptor for glucocorticoids (GC). Has a dual mode of action: as a transcription factor that binds to glucocorticoid response elements (GRE), both for nuclear and mitochondrial DNA, and as a modulator of other transcription factors. Affects inflammatory responses, cellular proliferation and differentiation in target tissues. Could act as a coactivator for STAT5-dependent transcription upon growth hormone (GH) stimulation and could reveal an essential role of hepatic GR in the control of body growth. Involved in chromatin remodeling. Plays a significant role in transactivation.<ref>PMID:21664385</ref>
 +
<div style="background-color:#fffaf0;">
 +
== Publication Abstract from PubMed ==
 +
A structure-based design approach led to the identification of a novel class of indazole ether based, non-steroidal glucocorticoid receptor (GR) modulators. Several examples were identified that displayed cell potency in the picomolar range, inhibiting LPS-induced TNF-alpha release by primary peripheral blood mononuclear cells (PBMCs). Additionally, an improved steroid hormone receptor binding selectivity profile, compared to classical steroidal GR agonists, was demonstrated. The indazole ether core tolerated a broad range of substituents allowing for modulation of the physiochemical parameters. A small sub-set of indazole ethers, with pharmacokinetic properties suitable for oral administration, was investigated in a rat antigen-induced joint inflammation model and demonstrated excellent anti-inflammatory efficacy.
-
Authors: Hemmerling, M., Edman, K., Lepisto, M., Eriksson, A., Ivanova, S., Dahmen, J., Rehwinkel, H., Berger, M., Hendrickx, R., Dearman, M., Jellesmark-Jensen, T., Wissler, L., Hansson, T.
+
Discovery of indazole ethers as novel, potent, non-steroidal glucocorticoid receptor modulators.,Hemmerling M, Edman K, Lepisto M, Eriksson A, Ivanova S, Dahmen J, Rehwinkel H, Berger M, Hendrickx R, Dearman M, Jensen TJ, Wissler L, Hansson T Bioorg Med Chem Lett. 2016 Dec 1;26(23):5741-5748. doi:, 10.1016/j.bmcl.2016.10.052. Epub 2016 Oct 19. PMID:27810243<ref>PMID:27810243</ref>
-
Description: Structure guided design and discovery of Indazole ethers as highly potent, non-steroidal Glucocorticoid receptor modulators
+
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
-
[[Category: Unreleased Structures]]
+
</div>
-
[[Category: Hemmerling, M]]
+
<div class="pdbe-citations 5g5w" style="background-color:#fffaf0;"></div>
-
[[Category: Eriksson, A]]
+
 
-
[[Category: Edman, K]]
+
==See Also==
-
[[Category: Hansson, T]]
+
*[[Glucocorticoid receptor 3D structures|Glucocorticoid receptor 3D structures]]
-
[[Category: Jellesmark-Jensen, T]]
+
== References ==
-
[[Category: Hendrickx, R]]
+
<references/>
-
[[Category: Ivanova, S]]
+
__TOC__
-
[[Category: Wissler, L]]
+
</StructureSection>
-
[[Category: Dearman, M]]
+
[[Category: Homo sapiens]]
-
[[Category: Berger, M]]
+
[[Category: Large Structures]]
-
[[Category: Dahmen, J]]
+
[[Category: Berger M]]
-
[[Category: Rehwinkel, H]]
+
[[Category: Dahmen J]]
-
[[Category: Lepisto, M]]
+
[[Category: Dearman M]]
 +
[[Category: Edman K]]
 +
[[Category: Eriksson A]]
 +
[[Category: Hansson T]]
 +
[[Category: Hemmerling M]]
 +
[[Category: Hendrickx R]]
 +
[[Category: Ivanova S]]
 +
[[Category: Jellesmark-Jensen T]]
 +
[[Category: Lepisto M]]
 +
[[Category: Rehwinkel H]]
 +
[[Category: Wissler L]]

Current revision

Structure guided design and discovery of Indazole ethers as highly potent, non-steroidal Glucocorticoid receptor modulators

PDB ID 5g5w

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools